AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇰🇪

Cabotegravir in Kenya

1 product registered with PPB 1 active

Brand / ProductReg. No.HolderStatusExpires
Apretude Injection
Suspension For Injection
H2024/CTD11489/21176GlaxoSmithKline Pharmaceutical Kenya Limitedactive30 Jul 2029

CabotegravirPPB Registration Details

PPB (Kenya) has 1 registered product containing Cabotegravir, of which 1 is currently active. Data is sourced directly from the official PPB drug register and refreshed daily.

Track Cabotegravir registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.